EXON 44

Clinical trials for EXON 44 explained in plain language.

Never miss a new study

Get alerted when new EXON 44 trials appear

Sign up with your email to follow new studies for EXON 44, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug aims to restore muscle protein in boys with DMD

Disease control Recruiting now

This study tests a weekly intravenous drug, NS-089/NCNP-02, in 20 boys aged 4 to 14 with Duchenne muscular dystrophy (DMD) who have a specific genetic mutation. The goal is to help their bodies produce a missing muscle protein, dystrophin, to slow muscle damage. Participants must…

Matched conditions: EXON 44

Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control

Last updated May 13, 2026 16:04 UTC

EXON 44

Get alerted when new EXON 44 trials appear

New drug aims to restore muscle protein in boys with DMD